American Century Companies Inc. Cuts Holdings in OR Royalties Inc. $OR

American Century Companies Inc. decreased its holdings in OR Royalties Inc. (NYSE:OR) by 34.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 378,817 shares of the basic materials company’s stock after selling 200,571 shares during the period. American Century Companies Inc. owned about 0.20% of OR Royalties worth $15,183,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Caitlin John LLC bought a new stake in OR Royalties during the third quarter valued at about $78,000. Eagle Global Advisors LLC bought a new position in OR Royalties in the third quarter worth about $206,000. Merit Financial Group LLC purchased a new stake in shares of OR Royalties during the third quarter valued at about $215,000. Smith Salley Wealth Management purchased a new stake in shares of OR Royalties during the third quarter valued at about $228,000. Finally, Envestnet Asset Management Inc. bought a new stake in shares of OR Royalties in the 3rd quarter valued at about $228,000. Hedge funds and other institutional investors own 68.52% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on OR shares. Weiss Ratings reissued a “buy (b)” rating on shares of OR Royalties in a research report on Monday, December 29th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $38.00 price target on shares of OR Royalties in a report on Sunday, December 7th. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of OR Royalties in a research report on Wednesday, February 4th. Wall Street Zen lowered OR Royalties from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 21st. Finally, Scotiabank raised their price objective on OR Royalties from $41.00 to $51.00 and gave the stock a “sector perform” rating in a research report on Monday, January 26th. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $38.25.

OR Royalties Stock Performance

Shares of OR opened at $43.63 on Wednesday. The stock has a 50-day moving average of $42.07 and a two-hundred day moving average of $37.52. OR Royalties Inc. has a one year low of $18.08 and a one year high of $48.06. The stock has a market cap of $8.18 billion, a P/E ratio of 40.03 and a beta of 0.75.

OR Royalties (NYSE:OR) last announced its quarterly earnings data on Wednesday, February 18th. The basic materials company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.31 by $0.01. The business had revenue of $90.47 million during the quarter, compared to analysts’ expectations of $90.80 million. OR Royalties had a net margin of 74.30% and a return on equity of 12.73%. Analysts predict that OR Royalties Inc. will post 0.62 EPS for the current fiscal year.

OR Royalties Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.055 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $0.22 dividend on an annualized basis and a yield of 0.5%. OR Royalties’s dividend payout ratio is 20.18%.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.